NCT02956369View on ClinicalTrials.gov

Effect of Daily Intake of SATIOSTAT Over 6 Weeks on Weight Loss, Glucose Tolerance, Gastrointestinal Tolerance and Gut Microbiota.

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 16, 2017

Primary Completion Date

May 6, 2019

Study Completion Date

May 6, 2019

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

Control

Control granulates (maize starch and long-chain fatty acids) with powder

DIETARY_SUPPLEMENT

SATIOSTAT

SATIOSTAT granulates (hydrocolloids (fibers) and long-chain fatty acids) with powder

Trial Locations (1)

4016

St Claraspital, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT02956369 - Effect of Daily Intake of SATIOSTAT Over 6 Weeks on Weight Loss, Glucose Tolerance, Gastrointestinal Tolerance and Gut Microbiota. | Biotech Hunter | Biotech Hunter